UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.012

Sortiert nach

Blood-based RAS mutation testing: concordance with tissue-based RAS testing and mutational changes on progression

Future oncology (London, England), 2020-10, Vol.16 (28), p.2177-2189

2020

Volltextzugriff (PDF)

Patients ’ and healthcare professionals ’ views on pharmacogenetic testing and its future delivery in the NHS

Pharmacogenomics, 2007-11, Vol.8 (11), p.1511-1519

2007

Volltextzugriff (PDF)

Patient experiences with pharmacogenetic testing in a primary care setting

Pharmacogenomics, 2016-10, Vol.17 (15), p.1629-1636

2016

Volltextzugriff (PDF)

Incorporation of pharmacogenetic testing into medication therapy management

Pharmacogenomics, 2015-11, Vol.16 (17), p.1931-1941

2015

Volltextzugriff (PDF)

Real-world genetic testing patterns in metastatic castration-resistant prostate cancer

Future oncology (London, England), 2021-08, Vol.17 (22), p.2907-2921

2021

Volltextzugriff (PDF)

Early adoption of pharmacogenetic testing for veterans prescribed psychotropic medications

Pharmacogenomics, 2019-07, Vol.20 (11), p.781-789

2019

Volltextzugriff (PDF)

Pharmacogenomics testing in a community pharmacy: patient perceptions and willingness-to-pay

Pharmacogenomics, 2017-02, Vol.18 (3), p.227-233

2017

Volltextzugriff (PDF)

Real-world homologous recombination repair mutation testing in metastatic castration-resistant prostate cancer in the USA, Europe and Japan

Future oncology (London, England), 2022-03, Vol.18 (8), p.937-951

2022

Volltextzugriff (PDF)

Patients and physicians perspectives on pharmacogenetic testing

Pharmacogenomics, 2006-01, Vol.7 (1), p.49-59

2006

Volltextzugriff (PDF)

Projected impact of pharmacogenomic testing on medications beyond antiplatelet therapy in percutaneous coronary intervention patients

Pharmacogenomics, 2020-05, Vol.21 (7), p.431-441

2020

Volltextzugriff (PDF)

A nationwide cross-sectional survey of pharmacy students on pharmacogenetic testing in The Netherlands

Pharmacogenomics, 2018-03, Vol.19 (4), p.311-319

2018

Volltextzugriff (PDF)

Understanding the state of pharmacogenomic testing for thiopurine methyltransferase within a large health system

Pharmacogenomics, 2020-04, Vol.21 (6), p.411-418

2020

Volltextzugriff (PDF)

Real-world multi-country study of BRCA1/2 mutation testing among adult women with HER2-negative advanced breast cancer

Future oncology (London, England), 2022-03, Vol.18 (9), p.1089-1101

2022

Volltextzugriff (PDF)

Pilot study of pharmacist-assisted delivery of pharmacogenetic testing in a primary care setting

Pharmacogenomics, 2014-10, Vol.15 (12), p.1677-1686

2014

Volltextzugriff (PDF)

Diagnostic and therapeutic value of intracellular biomarker testing in chronic pain

Pain management, 2024-01, Vol.14 (1), p.21-27

2024

Volltextzugriff (PDF)

Cognitive testing in the COVID-19 era: can existing screeners be adapted for telephone use?

Neurodegenerative disease management, 2021-02, Vol.11 (1), p.77-82

Larner, Andrew J

2021

Volltextzugriff (PDF)

Treatment and relapse in breast cancer show significant correlations to noninvasive testing using urinary and plasma DNA

Future oncology (London, England), 2020-05, Vol.16 (13), p.849-858

2020

Volltextzugriff (PDF)

Clinical and educational impact of pharmacogenomics testing: a case series from the INGENIOUS trial

Pharmacogenomics, 2017-06, Vol.18 (9), p.835-841

2017

Volltextzugriff (PDF)

Pharmacogenomic testing for mental health (Part I): documenting early adopter perceptions of use for eight scenarios

Personalized medicine, 2021-05, Vol.18 (3), p.223-232

2021

Volltextzugriff (PDF)

Pharmacogenomic testing for mental health (Part II): qualitative analysis of early adopter prescriber perceptions

Personalized medicine, 2021-05, Vol.18 (3), p.233-240

2021

Volltextzugriff (PDF)

Analysis of outpatient HER2 testing in New York state using the statewide planning and research cooperative system

Pharmacogenomics, 2018-12, Vol.19 (18), p.1395-1401

2018

Volltextzugriff (PDF)

Testing family-centered, function-focused care in hospitalized persons with dementia

Neurodegenerative disease management, 2015-06, Vol.5 (3), p.203-215

2015

Volltextzugriff (PDF)

β-blocker therapy and heart rate control during exercise testing in the general population: role of a common G-protein β-3 subunit variant

Pharmacogenomics, 2010-09, Vol.11 (9), p.1209-1221

2010

Volltextzugriff (PDF)

Real-world study of PD-L1 testing patterns and treatment distribution in patients with metastatic non-small-cell lung cancer in Israel

Immunotherapy, 2021-07, Vol.13 (10), p.851-861

2021

Volltextzugriff (PDF)

Impressions of pharmacogenomic testing among Certified Registered Nurse Anesthetists: a mixed-method study

Pharmacogenomics, 2016-04, Vol.17 (6), p.593-602

2016

Volltextzugriff (PDF)

1 – 25 von 1.012

Suche als RSS-Feed

Aktive Filter

KollektionSpringerLink

KollektionTaylor & Francis:Master (3349 titles)

SpracheRussisch

ThemaYoung Adult

KollektionTaylor & Francis Online

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.002)
Mit Volltextzugriff
(166)

Publikationsform

Artikel
(1.012)

Sprache

Englisch
(1.012)
Japanisch
(56)
Norwegisch
(1)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Blood-based RAS mutation testing: concordance with tissue-based RAS testing and mutational changes on progression

Patients ’ and healthcare professionals ’ views on pharmacogenetic testing and its future delivery in the NHS

Patient experiences with pharmacogenetic testing in a primary care setting

Incorporation of pharmacogenetic testing into medication therapy management

Real-world genetic testing patterns in metastatic castration-resistant prostate cancer

Early adoption of pharmacogenetic testing for veterans prescribed psychotropic medications

Pharmacogenomics testing in a community pharmacy: patient perceptions and willingness-to-pay

Real-world homologous recombination repair mutation testing in metastatic castration-resistant prostate cancer in the USA, Europe and Japan

Patients and physicians perspectives on pharmacogenetic testing

Projected impact of pharmacogenomic testing on medications beyond antiplatelet therapy in percutaneous coronary intervention patients

A nationwide cross-sectional survey of pharmacy students on pharmacogenetic testing in The Netherlands

Understanding the state of pharmacogenomic testing for thiopurine methyltransferase within a large health system

Real-world multi-country study of BRCA1/2 mutation testing among adult women with HER2-negative advanced breast cancer

Pilot study of pharmacist-assisted delivery of pharmacogenetic testing in a primary care setting

Diagnostic and therapeutic value of intracellular biomarker testing in chronic pain

Cognitive testing in the COVID-19 era: can existing screeners be adapted for telephone use?

Treatment and relapse in breast cancer show significant correlations to noninvasive testing using urinary and plasma DNA

Clinical and educational impact of pharmacogenomics testing: a case series from the INGENIOUS trial

Pharmacogenomic testing for mental health (Part I): documenting early adopter perceptions of use for eight scenarios

Pharmacogenomic testing for mental health (Part II): qualitative analysis of early adopter prescriber perceptions

Analysis of outpatient HER2 testing in New York state using the statewide planning and research cooperative system

Testing family-centered, function-focused care in hospitalized persons with dementia

β-blocker therapy and heart rate control during exercise testing in the general population: role of a common G-protein β-3 subunit variant

Real-world study of PD-L1 testing patterns and treatment distribution in patients with metastatic non-small-cell lung cancer in Israel

Impressions of pharmacogenomic testing among Certified Registered Nurse Anesthetists: a mixed-method study

Aktive Filter

Suchergebnisse filtern